Stem cells, progenitors and myelin repair.
Remyelination, the process by which new myelin sheaths are restored to demyelinated axons, represents one of the most compelling examples of adult multipotent progenitor cells contributing to regeneration of the injured central nervous system (CNS). This process can occur with remarkable efficiency in both clinical disease, such as multiple sclerosis, and in experimental models, revealing an impressive ability of the adult CNS to repair itself. However, the inconsistency of remyelination in multiple sclerosis, and the loss of axonal integrity that results from its failure, makes enhancement of remyelination an important therapeutic objective. Identifying potential targets will depend on a detailed understanding of the cellular and molecular mechanisms of remyelination. In this article we address two important issues. First, we consider the nature of the cell or cells that respond to demyelination and generate new oligodendrocytes, identifying current areas of uncertainty and addressing the role of adult CNS stem and progenitor cells. Second, we discuss the concept of adult progenitor activation following demyelination, focusing on the increased expression of (1) olig transcription factors, (2) bone morphogenetic proteins and (3) fyn, a member of the src-family of tyrosine kinases.
Zhao
Chao
C
Cambridge Centre for Brain Repair and The Neuroregeneration Laboratory, Department of Veterinary Medicine, University of Cambridge, UK.
Fancy
Stephen P J
SP
Magy
Laurent
L
Urwin
Joanna E
JE
Franklin
Robin J M
RJ
D019485:Bone Morphogenetic Proteins / Q000502:physiology; D049109:Cell Proliferation; D003711:Demyelinating Diseases / Q000473:pathology*; D006801:Humans; D039902:Multipotent Stem Cells / Q000502:physiology*; D009186:Myelin Sheath / Q000473:pathology*; D009416:Nerve Regeneration / Q000502:physiology*; D009836:Oligodendroglia / Q000473:pathology
D019485:Bone Morphogenetic Proteins